The key to the treatment of this disease lies in actively controlling infection, preventing recurrence, eliminating precipitating factors, correcting congenital or acquired urinary tract structural abnormalities, and preventing renal damage.
1. General treatment for acute infections should include bed rest, increased fluid intake, frequent urination to reduce the time bacteria stay in the bladder. Girls should pay attention to the cleanliness of the vulva and actively treat pinworms.
2. Antimicrobial therapy should be early and aggressive. Drug selection is generally based on:
① Infection site: For pyelonephritis, drugs with high blood concentrations should be chosen, while for lower urinary tract infections, drugs with high urine concentrations such as furan or sulfonamides should be chosen;
② Urine culture and drug sensitivity results;
③ Drugs with minimal renal damage. Acute primary infections are treated with the following drugs, with symptoms improving and bacteriuria disappearing within 2 to 3 days. If symptoms do not improve or bacteriuria persists after 2 to 3 days of treatment, it often indicates that the bacteria may be resistant to the drug, and an early adjustment should be made. Combination of two drugs may be used if necessary.
(1) Sulfonamide drugs: Due to their strong antibacterial effect on most Escherichia coli, high solubility in urine, and low resistance, they are inexpensive and often the first choice for initial infections. The common preparation is sulfamethoxazole (SME), which is often combined with the synergist trimethoprim (TMP) (i.e., co-trimoxazole SMZco). The dosage is 50 mg/(kg·d) taken twice a day. The general course of treatment is 1 to 2 weeks. To prevent crystallization in the urine, adequate fluid intake is recommended, and caution should be exercised in cases of renal insufficiency.
(2) Pipemidic acid (PPA): Effective for urinary tract infections caused by Escherichia coli due to its high excretion rate in urine, resulting in significant efficacy. Suitable for various types of urinary tract infections. Dosage is 30 to 50 mg/(kg·d), taken orally in 3 to 4 divided doses. Side effects are rare, with mild stomach discomfort possible. Caution should be exercised in children.
(3) Furazolidone: Has a wide range of antibacterial activity, has a significant effect on Escherichia coli, and is not easy to develop drug resistance. The dose is 8~10mg/(kg·d), taken orally in 3 divided doses. It is prone to gastrointestinal reactions and is recommended to be taken after meals. It can also be used in combination with TMP. It is more suitable to choose furazolidone for persistent infections that require continuous treatment for 3 to 4 months.
(4) Norfloxacin; It is a fully synthetic broad-spectrum antibacterial drug of the quinolone class, with strong antibacterial activity against Gram-negative and Gram-positive bacteria. The dose is 5~10mg/(kg·d), taken orally in 3~4 divided doses. Due to its strong antibacterial activity, long-term use can lead to dysbacteriosis, and attention should be paid when using it. Generally not used in children.
(5) Ampicillin,先锋霉素:Both are broad-spectrum antibiotics with good antibacterial activity and are often used for the treatment of urinary tract infections. Kanamycin and gentamicin have good antibacterial activity, but due to their nephrotoxicity and adverse effects on hearing, they should be used with caution.
3. Treatment course During acute infection, if the selected antibiotic is sensitive to bacteria, a general 10-day course of treatment can control the infection in the vast majority of patients, and a 5-day course may be sufficient if there is no fever. Regular follow-up should be conducted annually or longer after recovery. Because most recurrences are caused by reinfection, it is not recommended to use long-term therapy for all patients. Specific recommendations are as follows:
① For those who do not frequently relapse, acute treatment should be given after recurrence;
② For those who recurrently relapse, after controlling the acute symptoms, one can take a small dose (1/3 to 1/4 of the therapeutic dose) of SMZco, furazolidone, pipemidic acid, or norfloxacin before going to bed each night, and the course of treatment can last for 3 to 6 months. For those with repeated infections or renal parenchymal damage, the course of treatment can be extended to 1 to 2 years. To prevent the development of drug-resistant strains, combined medication or alternating medication can be used, that is, each drug is used for 2 to 3 weeks and then rotated, in order to improve the efficacy.
4. Approximately half of children with urinary tract infections associated with various etiologies can be actively treated for urinary tract structural abnormalities. Especially in chronic or recurrent urinary tract infections, urinary tract structural abnormalities are often present at the same time, and it is necessary to actively search for and treat them as soon as possible to prevent renal parenchymal damage.